首页> 外文期刊>The Internet Journal of Healthcare Administration >Weighing in on the Medicare Prescription Drug Benefit Plan
【24h】

Weighing in on the Medicare Prescription Drug Benefit Plan

机译:权衡Medicare处方药福利计划

获取原文
       

摘要

The purpose of this analysis is to look at the Medicare Prescription Plan and determine how well it is performing, obstacles that it will face, and the potential longevity of the plan. The Medicare prescription plan will not be an easy fix as there are complex problems with few easy answers. The plan provides much needed drug coverage for millions of Americans and most agree it is the socially responsible thing for the government to do; however, the plan will face sustainability challenges in the future from controlling costs, an aging population, and technological advances in medicine. Medicare was in deep financial trouble before the addition of the new prescription plan. The addition has put a further cost burden on an already weakened system. The plan was not well thought out from a financial stand point and will not be able to endure into the future in its current state.
机译:该分析的目的是查看“医疗保险处方计划”,并确定其执行情况,面临的障碍以及该计划的潜在寿命。 Medicare处方计划将不是一个容易解决的问题,因为存在复杂的问题,很少有简单的答案。该计划为数以百万计的美国人提供了急需的药物保险,并且大多数人认为这是政府的社会责任。但是,该计划将来将在控制成本,人口老龄化和医学技术进步方面面临可持续性挑战。在加入新的处方计划之前,医疗保险陷入了严重的财务困境。这种增加给已经薄弱的系统带来了进一步的成本负担。从财务角度出发,该计划没有经过深思熟虑,并且在当前状态下将无法承受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号